Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Precision Genomic Testing Market Size?
The market size for precision genomic testing has experienced a swift expansion in the past few years. It’s projected to escalate from $13.44 billion in 2024 to $15.00 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth during the historic period encompass the expanding availability of direct-to-consumer genetic examinations, enhanced collaboration among pharmaceutical and diagnostic corporations, a mounting emphasis on preventive health care, amplified adoption of companion diagnostics, and heightened consciousness about early disease identification.
Accelerated expansion is predicted for the precision genomic testing market in the forthcoming years, with its size forecasted to reach $23.11 billion in 2029, boasting a compound annual growth rate (CAGR) of 11.4%. The cause for this projected surge during the forecast period lies in factors such as an increased need for precision oncology solutions, a mounting emphasis on diagnosing rare diseases, a rise in population genomics initiatives investments, an upswing in the usage of multi-omics methods, and a surge in non-invasive prenatal testing demand. Keys trends during this period are improvements in next-generation sequencing technologies, breakthroughs in liquid biopsy techniques, incorporation of artificial intelligence in genomic examination, advancements in multi-omics data interpretation and new developments in direct-to-consumer genetic testing models.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25883&type=smp
Which Factors Are Steering Growth In The Precision Genomic Testing Market?
An increasing occurrence of genetic disorders is anticipated to spur the expansion of the precision genomic testing market in the future. Genetic disorders are medical conditions triggered by abnormalities in a person’s DNA, including single gene mutations, alterations in multiple genes, or shifts in chromosome structure or quantity. The heightened birth prevalence of genetic disorders is mainly attributable to the rise in maternal age, as older mothers are more likely to transfer chromosomal abnormalities such as down syndrome to their offspring. Precision genomic testing allows the precise identification and early detection of genetic disorders through the recognition of specific genetic mutations, consequently enabling personalized treatment approaches and targeted interventions. For example, Gene People, a charity registered in the UK, revealed in May 2025 that around 1 in 25 children are affected by genetic ailments, impacting over 2.4 million children and adults in the UK. Moreover, around 30,000 infants and children in the UK get diagnosed with a genetic condition annually. Consequently, the escalating prevalence of genetic disorders is fuelling the growth of the precision genomic testing market.
How Is The Precision Genomic Testing Market Organized By Different Segments?
The precision genomic testing market covered in this report is segmented –
1) By Product And Service: Consumables, Equipment, Services
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Technology, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems, Other Technologies
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Rare Diseases, Other Applications
4) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Consumables: Reagents And Kits, Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Library Preparation Kits, Sequencing Reagents, Polymerase Chain Reaction Assay Kits, Buffers And Enzymes
2) By Equipment: Next-Generation Sequencing Systems, Polymerase Chain Reaction Machines, Microarray Instruments, Deoxyribonucleic Acid Analyzers, Bioinformatics Workstations, Laboratory Automation Systems
3) By Services: Genomic Data Analysis Services, Laboratory Testing Services, Genetic Counseling Services, Clinical Interpretation Services, Contract Research Services, Custom Assay Development Services
What Current And Upcoming Trends Are Shaping The Precision Genomic Testing Market?
Prominent businesses in the precision genomic testing market are honing their focus on the creation of unique solutions, including ultra-sensitive circulating tumor deoxyribonucleic acid assays, to facilitate earlier and more pinpoint detection of cancer. These advanced assays are used to detect minuscule fragments of tumor-derived deoxyribonucleic acid within the blood, enabling the early and accurate identification of genetic mutations related to cancer. One such example is the launch of the ultra-sensitive Signatera genome molecular residual disease test in April 2025 by Natera Inc., a clinical genetic testing company based in the United States. By using whole genome sequencing of a patient’s tumor and matched normal deoxyribonucleic acid, the test can create a personalized assay, capable of detecting circulating tumor deoxyribonucleic acid right down to the level of one part per million. This extreme level of sensitivity promotes earlier and more precise detection of cancer recurrence, significantly improving treatment strategies and patient management across a range of cancer types.
Who Are The Most Influential Companies In The Precision Genomic Testing Market?
Major companies operating in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, Precision Genetics.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report
Which Region Dominates The Precision Genomic Testing Market Today?
North America was the largest region in the precision genomic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision genomic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25883&type=smp
Browse Through More Reports Similar to the Global Precision Genomic Testing Market 2025, By The Business Research Company
Precision Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/precision-diagnostics-global-market-report
Genomics Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report
Dna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
